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Abstract
Background: Cardiometabolic diseases are complex traits which are influenced by several single nucleotide polymorphisms
(SNPs). Thus, analysing the combined effects of multiple gene variants might provide a better understanding of disease risk
than using a single gene variant approach. Furthermore, studies have found that the effect of SNPs on cardiometabolic traits
can be influenced by lifestyle factors, highlighting the importance of analysing gene-lifestyle interactions.
Aims: In the present study, we investigated the association of 15 gene variants with cardiometabolic traits and examined
whether these associations were modified by lifestyle factors such as dietary intake and physical activity.
Methods: The study included 110 Minangkabau women [aged 25–60 years and body mass index (BMI) 25.13 ± 4.2 kg/m2]
from Padang, Indonesia. All participants underwent a physical examination followed by anthropometric, biochemical and
dietary assessments and genetic tests. A genetic risk score (GRS) was developed based on 15 cardiometabolic disease-
related SNPs. The effect of GRS on cardiometabolic traits was analysed using general linear models. GRS-lifestyle interactions
on continuous outcomes were tested by including the interaction term (e.g. lifestyle factor*GRS) in the regression model.
Models were adjusted for age, BMI and location (rural or urban), wherever appropriate.
Results: There was a significant association between GRS and BMI, where individuals carrying 6 or more risk alleles had
higher BMI compared to those carrying 5 or less risk alleles (P = 0.018). Furthermore, there were significant interactions of
GRS with protein intake on waist circumference (WC) and triglyceride concentrations (Pinteraction = 0.002 and 0.003,
respectively). Among women who had a lower protein intake (13.51 ± 1.18% of the total daily energy intake), carriers of six
or more risk alleles had significantly lower WC and triglyceride concentrations compared with carriers of five or less risk
alleles (P = 0.0118 and 0.002, respectively).
Conclusions: Our study confirmed the association of GRS with higher BMI and further showed a significant effect of the
GRS on WC and triglyceride levels through the influence of a low-protein diet. These findings suggest that following a lower
protein diet, particularly in genetically predisposed individuals, might be an effective approach for addressing
cardiometabolic diseases among Southeast Asian women.
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Introduction
Cardiometabolic diseases such as cardiovascular diseases
(CVD), obesity, hypertension and type 2 diabetes are a major
cause of mortality, morbidity and healthcare spending world-
wide [1, 2]. The prevalence of these diseases has significantly
increased and has become a major problem given the signifi-
cant economic burden that these diseases impose on low-
and middle-income countries. Indonesia has the seventh lar-
gest number of diabetic patients (7.6 million), despite rela-
tively low prevalence worldwide (4.8%) in 2012 [3]. In 2013,
it was estimated that there were more than 132.8 million
people with diabetes in the Western Pacific (more people
than in any other region), and the number is expected to rise
to 201.8 million by 2035 [4]. Furthermore, obesity is sug-
gested to play a critical role in the development of chronic
and non-communicable diseases (NCDs) in the Southeast
(SE) Asia [5]. In Indonesia, NCDs are estimated to account
for 73% of all deaths [6] of which, CVD contributed to 35%
followed by cancers (12%) and diabetes (6%) [6].
Indonesia is the largest island country in the
world, consisting of various ethnic groups distributed
over 33 provinces [7]. Minangkabau community is
the world’s largest matrilineal society which resides
mostly in West Sumatra, where the prevalence of
low level of high-density lipoprotein cholesterol
(HDL-C), hypertension and central obesity is more
than 50% [7]. It is reported that the Minangkabau
ethnic group had a high risk of dyslipidemia, which
is suggested to be driven mainly by the high intake
of dietary fat from poor quality sources [8]. A study
comparing lipid profiles among four ethnic groups
reported that the Minangkabau ethnic group has the
highest levels of plasma total cholesterol and low-
density lipoprotein cholesterol (LDL-C) compared to
other larger ethnicities including Sundanese, Javanese
and Buginese [9]. Furthermore, it has been reported
that the prevalence of central obesity is high among
Minangkabau women [10]. Many environmental ex-
posures contribute to the increasing prevalence of
cardiometabolic diseases, but one key factor is ur-
banisation [11]. Countries in SE Asia have under-
gone rapid epidemiological and nutritional
transitions over the past few decades. Furthermore,
it has been reported that dietary risks, high blood
pressure and tobacco smoking are the three major
risk factors contributing to disease burden in
Indonesia [12]. However, genetic factors also play an
important role in the development of cardiometa-
bolic diseases.
Candidate gene studies and genome-wide association
studies (GWAS) have identified several single nucleotide
polymorphisms (SNPs) relating to cardiometabolic dis-
eases and traits in the Asian populations [13–16]. Most
cardiometabolic traits are influenced by thousands of
SNPs each having a relatively small effect on the trait
when present alone. Thus, analysing the combined ef-
fects of multiple gene variants might provide a better
understanding of trait variability of an individual and im-
prove risk prediction of cardiometabolic diseases than
using a single variant approach [17]. Furthermore, stud-
ies have found that the effect of genetic variants on car-
diometabolic traits can be influenced by lifestyle factors
[18]. It has been confirmed that using genetic risk score
(GRS) approaches increases the power to detect gene-
lifestyle interactions compared to the common single
variant methods [19]. Therefore, our study aimed to in-
vestigate the association of a novel GRS with cardiomet-
abolic traits and to examine whether lifestyle factors
such as dietary intake and physical activity modified
these associations in 110 Minangkabau women.
Methods
Study participants
The study included healthy women who were enrolled
in the Minangkabau Indonesia Study on Nutrition and
Genetics (MINANG) study, a cross-sectional pilot study
conducted in the city of Padang, West Sumatra,
Indonesia, between December 2017 and January 2018.
This study is a part of the ongoing GeNuIne (gene-nutri-
ent interactions) Collaboration, which aims to examine
the interactions between genetic and dietary factors
(nutrigenetics) on cardiometabolic disease and its related
traits using population-based studies from several ethnic
groups [20]. The methodology of the study has been
published elsewhere [21]. In brief, 133 women were re-
cruited from community health centres in two sub-
districts in Padang City including Padang Timur and
Kuranji districts to represent both urban and rural areas
of Padang population, respectively. The inclusion criteria
included healthy women, aged 25–60 years old and with
Minangkabau ethnicity. Of the 133 enrolled women, 10
were excluded from the study according to the following
exclusion criteria: being pregnant or lactating (N = 0) and
taking dietary or vitamin supplements (N = 0); have a pre-
vious history of hypertension, CVD or type 2 diabetes (N
= 6); have a body mass index (BMI) of more than 40 kg/
m2 or being classified as morbidly obese by a practitioner
(N = 0); being blood related to other participants in the
study (N = 0); have any communicable disease (N = 4). Of
the remaining 123 participants, we excluded another 5
women who did not undergo blood sampling. Thus, the
final sample consisted of 118 participants, of whom seven
women did not have complete genetic information about
all the investigated SNPs and were excluded from the GRS
analysis (N = 111). Additionally, one participant with no
dietary information available was excluded from the GRS
interaction analysis (N = 110).
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The MINANG study was conducted according to the
principles of the Declaration of Helsinki and was ap-
proved by the Ethical Review Committee of the Medical
Faculty, Andalas Univesity (No.311/KEP/FK/2017). All
participants gave their written informed consent before
participating and had the right to withdraw from the
study at will and opt-out from any of the procedures.
Anthropometric measures
Body weight (to the nearest 100 g) and height (to the near-
est mm) were measured using an electronic scale (Seca
803, Seca GmbH. Co. kg, Hamburg, Germany) and a wall-
mounted stadiometer (OneMed Medicom stature meter,
YF.05.05. V.A.1022, Indonesia), respectively. BMI was cal-
culated as weight (kg)/height (m)2 and categorised accord-
ing to the Asia-Pacific classification of BMI [22]. Waist
circumference (WC) was measured in centimetre using a
metal tape (Medline-OneMed Medicom, Jakarta,
Indonesia) midway between the 12th rib and the superior
border of the iliac crest at the end of normal expiration.
Biochemical and clinical measures
After 12 h of fasting, blood samples (5 ml) were taken to
measure the concentrations of glucose, insulin, glycated
haemoglobin A1c (HbA1c), total cholesterol, triglycer-
ides, LDL-C and HDL-C. Samples were assayed using
the xMark Microplate Spectrophotometer (Bio-Rad La-
boratories Inc, Hercules, California, USA). Fasting glu-
cose, insulin and HbA1c were measured using enzyme-
linked immunosorbent assay (ELISA) kits from Bioassay
Technology Laboratory (Shanghai, China). Blood lipids
were analysed using enzymatic colorimetric procedures,
namely GPO-PAP for triglycerides and CHOD-PAP for
total cholesterol, LDL and HDL. A sphygmomanometer
was used to measure systolic and diastolic blood pres-
sures (SBP and DBP). Measurements were taken twice at
5-min intervals, and the average was recorded.
Assessment of dietary intake and physical activity
Information about dietary intake and physical activity was
collected by a well-trained nutritionist in the home or in
an integrated health service post. Diet was assessed using
a previously validated and published semi-quantitative
food frequency questionnaire (SQ-FFQ) consisting of a list
of 223 food items [23]. Briefly, participants were asked to
report the frequency of consumption (number of times
per day, week or month) and portion size of various food
items. Participants were provided with portion size images
of all relevant foods to enhance reporting accuracy while
completing the SQ-FFQ [24]. All collected data were
double-checked for accuracy and analysed with the Indo-
nesian Food Database and Nutrisurvey (EBISpro,
Germany) to estimate total energy and macronutrient in-
take. Values of nutrient intake were adjusted for total
energy intake using the nutrient (energy-adjusted) residual
method, wherever appropriate [25].
“The Global Physical Activity Questionnaire” (GPAQ)
was used to calculate an individual’s level of physical ac-
tivity in 3 areas (work, transport and leisure-time) and
time spent in sedentary behaviour [26]. Total time spent
in moderate-to-vigorous physical activity was estimated
using to the World Health Organization (WHO) STEP-
wise method and was expressed as metabolic equivalent
minutes per day (METmins/day). Participants were de-
fined as “active” if they did ≥ 600 METmins/week or “in-
active” if they accumulated < 600 METmins/week.
SNP selection and genotyping
Fifteen genetic variants located at 8 different genes were
selected for the present study based on its consistent asso-
ciations with cardiometabolic traits in candidate gene
studies and GWAS in Asian populations [13–16, 27–36].
The selected genetic variants were Calpain 10 (CAPN10)
rs3792267 and rs5030952; fat mass and obesity-associated
(FTO)- rs9939609, rs10163409 and rs8050136; melanocor-
tin 4 Receptor (MC4R)- rs17782313 and rs2229616; tran-
scription factor 7-like 2 (TCF7L2)- rs12255372 and
rs7903146; potassium voltage-gated channel subfamily Q
member 1 (KCNQ1)- rs2237895 and rs2237892; cyclin-
dependent kinase inhibitor 2A/2B (CDKN2A/2B)-
rs10811661; peroxisome proliferator-activated receptor
gamma (PPARG)- rs1801282; and adiponectin (ADIPOQ)-
rs266729 and rs17846866.
Genomic DNA was extracted from peripheral
blood leukocytes using the PureLink Genomic DNA
Mini Kit (Invitrogen, Carlsbad, USA). Furthermore, a
NanoDrop spectrophotometer was used to determine
DNA concentration. The SNPs were genotyped using




Statistical analysis was performed using the SPSS soft-
ware (version 23). Common obesity was defined based
on the Asia-Pacific classification of BMI for Asians,
where non-obese individuals (BMI < 23 kg/m2) and
obese individuals (BMI ≥ 23 kg/m2) were classed accord-
ingly [37]. Central obesity was defined based on WHO
classification of WC (WC > 80 cm for women) [38]. The
Hardy-Weinberg equilibrium (HWE) was assessed using
the x2 goodness-of-fit test, and the 15 SNPs were in
HWE (P > 0.05). Normality of distribution of all con-
tinuous variables was tested using the Shapiro-Wilk test
and those that were not normally distributed were nat-
ural log-transformed before the analysis, including glu-
cose, insulin, HbAC1, HDL-C, LDL-C, total cholesterol,
triglyceride concentrations and total dietary protein
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intake (%). Continuous variables are expressed as means
and standard deviations (SD), and comparisons between
groups were made using the independent t test. The de-
scriptive statistics for categorical variables, such as phys-
ical activity level, were obtained by determining
frequency distributions and compared between individ-
uals with and without central obesity using Pearson’s
chi-squared test. The association between individual
SNPs and cardiometabolic traits was analysed using gen-
eral linear models adjusted for age, residential area (rural
or urban) and BMI when BMI is not an outcome. As the
number of individuals with rare homozygous genotypes
was low, a dominant model was used, where common
homozygous genotypes were compared against com-
bined rare homozygous and heterozygous genotypes.
A GRS was constructed based on 15 SNPs from 8
genes. An additive genetic model was assumed for each
gene variant, assigning a score of 0, 1 and 2 to genotypes
containing 0, 1 or 2 risk alleles, respectively. The GRS
was then calculated for each individual by summing the
number of risk alleles in the genetic variants. The count
method assumed that each risk allele contributes equally
and independently to the development of cardiometa-
bolic traits. The average number of risk alleles per indi-
vidual for the GRS was 5.12 (SD = 2.06), which ranged
from 2 to 10. The GRS variable was then categorised
into two groups based on the median of risk alleles: “low
genetic risk group”—individuals with a GRS ≤ 5 risk al-
leles (N = 69) and “high genetic risk group”—individuals
with GRS > 5 risk alleles (N = 42). The effects of GRS
on cardiometabolic traits were analysed using general
linear models. Furthermore, GRS-lifestyle interactions
on continuous outcomes were tested using linear regres-
sion models by including the interaction terms (e.g.
diet*genotype) in these models. Models were adjusted
for age, residential area and additionally for BMI when it
is not an outcome. Lifestyle factors that were investi-
gated in our study included dietary intake and physical
activity. Carbohydrate, protein and fat intakes were
expressed as a percentage of total energy intake, and fibre
intake was expressed in grammes. Furthermore, statisti-
cally significant interactions were investigated in more
depth, where individuals were stratified by the tertiles of
dietary intake and the levels of physical activity. A P value
of < 0.05 was considered statistically significant. Multiple
testing correction was not applied given that we had ex-
amined only one genetic instrument (i.e. GRS).
Results
Characteristics of the study participants according to the
central obesity status
In the present study, 71 women (64.0%) were centrally
obese and 39 (35.1%) were not. The characteristics of the
participants are shown in Table 1. In general, centrally
obese participants were older and had higher SBP (P =
0.006), fasting plasma glucose (P = 0.039), serum triglycer-
ides (P < 0.001), serum total cholesterol (P < 0.001) and
LDL-C (P < 0.001) concentrations compared to partici-
pants without central obesity. There were no significant
differences in fasting HDL-C, serum insulin, HbA1c, DBP,
dietary intake and physical activity levels and the distribu-
tion of GRS between the two groups (P > 0.05).
Associations between GRS and cardiometabolic traits
To explore the combined effect of the 15 SNPs on vari-
ous cardiometabolic traits, a GRS was calculated. There
was a significant association (P = 0.018) between the
GRS and BMI where individuals carrying 6 or more risk
alleles of the SNPs had higher BMI compared with those
carrying 5 or less risk alleles (Table 2).
Interactions between GRS and dietary intake on
cardiometabolic traits
There were significant interactions between the GRS and
protein intake (%) on WC and triglyceride concentrations
(Pinteraction = 0.002 and 0.003, respectively) (Table 3). With
low protein intake (13.51 ± 1.18%), carriers of 6 or more
risk alleles of SNPs had lower WC and triglyceride con-
centration compared to carriers of 5 or less risk alleles (P
= 0.0118 and 0.002, respectively) (Figs. 1 and 2). A signifi-
cant interaction between protein intake and GRS was also
detected on cholesterol levels (Pinteraction = 0.021). More-
over, there were no other interactions between nutrient
intake and GRS on cardio-metabolic traits.
Associations between individual SNPs and
cardiometabolic traits
As shown in supplementary Table 1, Additional File 1,
we found that the risk alleles of the three FTO SNPs
rs9939609, rs8050136 and rs10163409 were associated
with higher BMI (P = 0.006, 0.007 and 0.047, respect-
ively). Furthermore, SNPs rs12255372 (TCF7L2),
rs2237892 (KCNQ1) and rs5030952 (CAPN10) were as-
sociated with increased fasting serum LDL-C concentra-
tions (P = 0.032, 0.039 and 0.04, respectively). A
significant association was also found between the risk
allele of the SNP rs17782313 (MC4R) and higher insulin
level (P = 0.036). No significant association was observed
between the remaining SNPs and cardiometabolic traits
in this population (P > 0.05).
Discussion
The present study aimed to investigate the effects of
genetic predisposition and lifestyle factors on cardiomet-
abolic traits in Minangkabau women. In agreement with
other studies [39], we have shown that the GRS based
on 8 susceptible genes for cardiometabolic diseases is a
significant risk factor for higher BMI in our study
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sample and might be a useful tool in characterising Mi-
nangkabau women at high risk for obesity. We found
that women carrying 6 or more alleles had significantly
higher BMI compared to those carrying 5 or less risk al-
leles. Furthermore, we found a significant interaction be-
tween the GRS and dietary protein intake (%) on WC
and triglyceride levels, where, among those who con-
sumed a low protein diet (mean intake ± SD 13.51 ±
1.18%), individuals, despite carrying more than 6 risk al-
leles, had significantly lower WC and triglyceride levels.
Given that Minangkabau women have a high risk of dys-
lipidemia [9] and the prevalence of common and central
obesity is high among this ethnic group [10], it is
important to develop effective strategies targeting these
conditions to improve public health.
It has been suggested that centrally obese participants
defined as normal weight based on BMI had the worst
long-term survival even when compared with their over-
weight and obese counterparts [40]. In addition, recent
data from 42,702 European participants reported that
central obesity is associated with higher mortality risk
even in normal-weight individuals [41]. This is of con-
cern for Asian populations, where increased levels of vis-
ceral adiposity are observed in those with normal BMIs
[42–44]. Furthermore, the combination of increased WC
along with elevated triglyceride levels has been
Table 1 Anthropometric and biochemical characteristics of the study participants
N Total (N = 111) N Non-centrally obese (WC ≤ 80 cm) (N =
39)




Age (years) 111 40.49 ± 10.18 39 37.08 ± 11.68 71 42.58 ± 8.62 0.012
BMI (kg/m2) 111 25.13 ± 4.2 39 21.85 ± 3.71 71 26.99 ± 3.24 < 0.001
WC (cm) 110 83.85 ± 10.27 39 72.79 ± 6.03 71 89.92 ± 6.26 < 0.001
Glucose (mg/dl) 111 92.53 ± 20.67 39 87.21 ± 9.78 71 95.69 ± 24.29 0.039
Insulin (mIU/L) 111 32,428.5 ± 25,
706.13
39 31,073.79 ± 28,460.35 71 33,374.28 ± 24,368.83 0.657
HbA1c (ng/ml) 111 655.59 ± 601.59 39 629.22 ± 671.07 71 666.42 ± 568.14 0.759
Triglycerides (mg/dl) 111 98.8 ± 43.47 39 78.26 ± 34.19 71 109.72 ± 44.38 < 0.001
Cholesterol (mg/dl) 111 209.31 ± 44.02 39 188.26 ± 30.04 71 221.77 ± 45.74 < 0.001
HDL-C (mg/dl) 111 59.12 ± 10.29 39 60.9 ± 10.45 71 58.14 ± 10.22 0.182
LDL-C (mg/dl) 111 128.12 ± 39.85 39 111.49 ± 25.55 71 138.2 ± 42.65 < 0.001
SBP (mmHg) 111 113.37 ± 9.07 39 110.14 ± 8.83 71 115.05 ± 8.81 0.006
DBP (mmHg) 111 77.44 ± 6.39 39 76.26 ± 8.35 71 78.06 ± 5.01 0.223
Total energy (kcal/
day)
110 1776.24 ± 611.43 39 1789.55 ± 604.31 70 1755.6 ± 613.59 0.781
Carbohydrate intake
(%)
110 53.97 ± 9.44 39 52.67 ± 7.86 70 54.91 ± 10.1 0.235
Protein intake (%) 110 16.93 ± 3.32 39 17.13 ± 2.93 70 16.76 ± 3.54 0.579
Fat intake (%) 110 28.95 ± 7.99 39 30.05 ± 6.87 70 28.16 ± 8.45 0.235
Dietary fibre (g) 110 8.78 ± 4.29 39 9.11 ± 4.52 70 8.56 ± 4.19 0.521
SFA (g) 110 20.84 ± 11.22 39 21.77 ± 10.81 70 20.07 ± 11.35 0.447
MUFA (g) 110 8.18 ± 4.6 39 9.00 ± 5.08 70 7.62 ± 4.18 0.129
PUFA (g) 110 6.32 ± 3.5 39 6.67 ± 3.06 70 6.14 ± 3.76 0.541
MET (min/week) 111 1311.89 ± 1877.78 39 1114.87 ± 1625.95 71 1428.45 ± 2016.27 0.407
GRS 110 5.09 ± 2.07 39 4.77 ± 2.01 71 5.31 ± 2.03 0.189
Physical activity levels 44 Sedentary
(39.64%)
18 Sedentary (46.15%) 26 Sedentary (36.62%) 0.616
55 Moderate
(49.55%)
17 Moderate (43.59%) 37 Moderate (52.11%)
12 Vigorous (10.81%) 4 Vigorous (10.26%) 8 Vigorous (11.27%)
Data presented as means ± SD for continuous variables and as percentages for categorical variables
BMI body mass index, WC waist circumference, HbA1C glycated haemoglobin A1c, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein
cholesterol, SBP systolic blood pressure, DBP diastolic blood pressure, SFA saturated fatty acids, MUFA monounsaturated fatty acids, PUFA polyunsaturated fatty
acids, MET metabolic equivalent of task, GRS genetic risk score
*P values for the differences in the means and proportions between non-centrally obese and centrally obese individuals were calculated using the independent t
test and the Chi-squared test, respectively
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previously defined as the ‘hypertriacylglycerolaemic
waist’ phenotype [45]. Studies have shown that individ-
uals with this phenotype have an increased risk of higher
visceral adiposity, CVD, insulin resistance and other re-
lated outcomes [45]. Therefore, targeting this phenotype
will have significant public health implications in terms
of reducing NCD mortality in Asian populations.
In the present study, the average protein intake was 77
± 37 g/day, which exceeded the recommended dietary
protein daily allowance of 57–59 g/day for Indonesian
women [46, 47]. Observational studies have shown that
higher protein intake was significantly associated with
increases in body weight, BMI and fat mass [48–50].
These results are in contrast to the finding from
intervention studies, which have shown that high protein
intake enhances weight loss and provides a better long-
term maintenance of reduced intra-abdominal fat stores
[37, 51]. These inconsistencies might be attributed to
the sample size, genetic heterogeneity and gene-lifestyle
interactions. Cross-sectional studies have demonstrated
the association of several SNPs with obesity-related traits
[52–55], and interaction of these SNPs with dietary in-
take of protein on weight change [56–58]. It has been
shown that high protein diets can modulate the genetic
effect of FTO variants on body weight, BMI and WC
[59–61]. According to a 2-year weight loss intervention
programme, carriers of the risk allele ‘A’ of the FTO
SNP rs1558902 had a greater reduction in weight and
Table 2 Associations between GRS and cardiometabolic traits
GRS ≤ 5 (N = 69) GRS > 5 (N = 42) P value*
N Mean ± SE N Mean ± SE
BMI (kg/m2) 69 24.52 ± 0.52 42 26.14 ± 0.6 0.018
WC (cm) 68 84.28 ± 1.22 42 83.16 ± 1.66 0.334
Log glucose (mg/dl) 69 93.65 ± 2.98 42 90.69 ± 1.72 0.327
Log insulin (mIU/L) 69 32,365.29 ± 3199.95 42 32,532.33 ± 3782.96 0.196
Log HbA1C (ng/ml) 69 650.58 ± 71.1 42 663.81 ± 96.65 0.527
Log triglycerides (mg/dl) 69 101.07 ± 5.27 42 95.07 ± 6.67 0.142
Log cholesterol (mg/dl) 69 212.88 ± 5.59 42 203.43 ± 6.11 0.228
Log HDL-C (mg/dl) 69 58.55 ± 1.26 42 60.05 ± 1.56 0.404
Log LDL-C (mg/dl) 69 131.84 ± 4.97 42 122 ± 5.73 0.197
Log SBP (mmHg) 69 113.12 ± 1.08 42 113.77 ± 1.43 0.679
Log DBP (mmHg) 69 77.59 ± 0.86 42 77.2 ± 0.76 0.535
BMI body mass index, WC waist circumference, HbA1C glycated haemoglobin A1c, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein
cholesterol, SBP systolic blood pressure, DBP diastolic blood pressure
*P values obtained from linear regression analysis adjusted for age, residential area and additionally for BMI when BMI is not an outcome. The analysis was
performed on log-transformed variables
Table 3 Interactions between GRS and lifestyle factors on cardio-metabolic traits
Carbohydrate (%) Protein (%) Fat (%) Fibre (g) Physical activity
BMI (kg/m2) 0.961 0.282 0.721 0.876 0.362
WC (cm) 0.224 0.002 0.577 0.614 0.297
Log glucose (mg/dl) 0.882 0.751 0.732 0.833 0.106
Log insulin (mIU/L) 0.336 0.341 0.48 0.216 0.909
Log HbA1C (ng/ml) 0.766 0.638 0.935 0.162 0.626
Log triglycerides (mg/dl) 0.066 0.003 0.355 0.262 0.479
Log cholesterol (mg/dl) 0.081 0.021 0.261 0.583 0.308
Log HDL-C (mg/dl) 0.978 0.905 0.984 0.323 0.540
Log LDL-C (mg/dl) 0.266 0.337 0.431 0.896 0.721
Log SBP (mmHg) 0.156 0.291 0.208 0.872 0.644
Log DBP (mmHg) 0.966 0.815 0.732 0.292 0.743
Data are P values obtained from linear regression analysis adjusted for age, residential area and BMI when BMI is not an outcome. The analysis was performed on
log-transformed variables
BMI body mass index, WC waist circumference, HbA1C glycated haemoglobin A1c, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein
cholesterol, SBP systolic blood pressure, DBP diastolic blood pressure
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regional fat compared to non-carriers when high protein
diets were consumed, whereas an opposite genetic effect
was found on changes in fat distribution in response to a
low-protein intake [60]. However, studies investigating
the joint effect of genetic variants have reported conflict-
ing results [62–64], indicating that the influence of gen-
etic predisposition on changes in body weight and WC
does not seem to be modulated by protein intake. In
contrast, the present study provides evidence for GRS-
protein intake interactions on WC and triglyceride con-
centrations, and these interactions were independent of
potential confounding effects. We found that partici-
pants with 6 or more risk alleles who consumed a low
protein diet (mean intake ± SD 13.51 ± 1.18%) had sig-
nificantly lower WC and triglyceride concentrations
compared to those with 5 or less risk alleles. This
Fig. 1 Interaction between genetic risk score (GRS) and log protein intake (%) on waist circumference (WC). White bars indicate “low genetic risk
group”: individuals with a GRS ≤ 5 risk alleles; black bars indicate “high genetic risk group”: individuals with GRS > 5 risk alleles. Carriers of 6 or
more risk alleles had lower WC compared to carriers of 5 or less risk alleles, among individual with lower protein intake (13.51 ± 1.18%)
Fig. 2 Interaction between genetic risk score (GRS) and log protein intake (%) on log triglyceride levels. White bars indicate “low genetic risk
group”: individuals with a GRS ≤ 5 risk alleles; black bars indicate “high genetic risk group”: individuals with GRS > 5 risk alleles. Carriers of 6 or
more risk alleles had lower triglyceride level compared to carriers of 5 or less risk alleles, among individual with lower protein intake (13.51 ± 1.18%)
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difference in the findings across the studies might be
due to differences in the sample size, methods used to
construct GRSs (weighted vs. unweighted) and the num-
ber of SNPs included in the GRSs.
The observed interaction between GRS and dietary
protein on WC and triglyceride concentrations might be
driven by the source of protein consumed, which has
not been analysed in our study. Different protein
sources have different effects on body weight and fat
mass, and the mechanisms behind this are still very
speculative and need more investigation. The higher in-
take of protein from animal sources (protein from red
and processed meat and poultry) was found to be asso-
ciated with an increase in body weight in both genders,
with a stronger association in women [49]. Diet rich in
animal protein might reflect the western pattern diet
characterised by high red meat consumption, which has
shown to be associated with weight gain [65]. In con-
trast, a study has shown that protein from meat is asso-
ciated with lower weight gain because it produces a
higher 24-h energy expenditure compared to soy protein
[66]. This hypothesis is, however, based on a mechanis-
tic study, and it is still unknown whether this applies in
the long run to individuals of the free-living popula-
tions. Furthermore, it has been suggested that consum-
ing protein from dairy sources may prevent weight gain
and promote abdominal fat loss [67]. Here, the sug-
gested mechanism primarily relates to the high content
of calcium, which may function synergistically in com-
bination with bioactive compounds, such as
angiotensin-converting enzyme inhibitors and the rich
concentration of branched-chain amino acids [67].
While the above-mentioned studies failed to explore the
genetic aspects, our study did not investigate the type of
protein that was consumed by the participants; hence,
future studies examining the effect of both factors are
required.
In agreement with some studies [62, 63], no inter-
actions were detected between GRS and dietary in-
take of protein, fat and carbohydrate on BMI in the
present study. However, a study in the European
population (N = 48,170 adults) has shown that the
joint effect of 93 obesity-related SNPs on BMI might
be modulated by the intake of total energy, fat and
saturated fat [64]. Furthermore, studies have shown
that an obesogenic diet and physical inactivity with
relatively high intake of sugar-sweetened beverages
and prolonged television watching might exaggerate
the effect of genetic factors on adiposity [18, 68].
Even though several studies have demonstrated that
physical activity could attenuate the combined gen-
etic influence of multiple SNPs on BMI and obesity
risk [18, 69, 70], no such interactions were detected
in the present study.
The strengths of our study include the use of a
well-defined population, a validated SQ-FFQ [23]
and a genetic risk score generated from the 15 gen-
etic variants associated with cardiometabolic traits.
Also, the main exposures investigated in our study
were collected by well-trained staff and using vali-
dated and standardised operating procedures. How-
ever, there are limitations that need to be
acknowledged. Although our analysis was adjusted
for several factors, the potential for confounding by
unmeasured or unknown factors exist. Even though
our study has a small sample size, we were still able
to find significant associations and interactions sug-
gesting that our study is well powered. Even though
food intake was assessed using validated methods,
recall bias and measurement errors in these self-
reported FFQs cannot be fully eliminated, which
could alter the true underlying interactions between
dietary and genetic factors on cardiometabolic traits
[71, 72]. Finally, our study was restricted to Mi-
nangkabau women, and it is unknown whether our
findings could be generalised to men or other
demographic or ethnic groups.
Conclusion
In the present study, we have shown a significant
effect of the GRS on WC and triglyceride levels
through the influence of a low protein intake,
where individuals with a high genetic susceptibility
can overcome the risk of higher WC and triglycer-
ide levels by consuming a low protein diet. These
findings are potentially relevant for public health;
however, future trials in both genders with larger
sample size and objective measures of protein in-
take, such as urinary nitrogen, are needed to con-
firm these findings.
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